Can monolithic zirconia frameworks in implant-supported cross-arch prostheses deliver reliable long-term outcomes?

A Commentary on

Luo J, Zhang Y, Yu Z et al.

A retrospective single cohort study on the 5–13-year clinical outcomes of implant-supported cross-arch fixed dental prostheses with monolithic zirconia-based frameworks. J Prosthodont 2024; https://doi.org/10.1111/jopr.13991.

GRADE Rating: Medium

Commentary

The 2018 ITI Consensus Report highlights the potential of implant-supported monolithic zirconia prostheses as a promising option, subject to further supporting evidence1. Zirconia frameworks show promising short-term outcomes, with survival rates for full-arch zirconia rehabilitations ranging from 88% to 100% at 7 years2. However, comprehensive analyses of mid-to-long-term clinical performance of screw-retained monolithic zirconia IFCDPs and associated risk factors remain limited3.

The study’s strengths lie in its comprehensive evaluation of both biological (peri-implantitis) and technical complications (framework fractures), offering a holistic view of the performance of zirconia-based IFCDPs4. Longitudinal data over 5–13 years, offer rare insights into prosthesis survival and the progression of complications, addressing a significant gap in existing literature. Based on the CASP checklist, the study had clear aims, employed an appropriate retrospective methodology following STROBE guidelines, measured outcomes using standardised records and USPHS criteria. The use of mixed-effects Cox regression models to assess correlations between clinical variables and complications, enhances statistical rigour. The analysis accounted for clustering effects from multiple implants or prostheses per patient and evaluated variables such as jaw type, implant count, cantilever presence, and opposing dentition.

Whilst the findings of this study reinforce the viability of monolithic zirconia frameworks, it also highlights specific challenges, underscoring the complex interplay between material properties and anatomical factors. The natural flexure of the mandible generates bending stresses, resulting in deformation during mandibular movement, particularly in the symphyseal region. It has been suggested that the non-ductile nature of monolithic zirconia may insufficiently resist these stresses, resulting in stress concentration at critical points, such as the osseointegration interface of implants and the connection interface between implants and the superstructure. Clinically, the study’s identification of mandibular flexure as a significant risk factor for framework fractures and peri-implantitis, challenges assumptions of uniform performance across jaws. In turn, highlighting the importance of anatomical considerations in treatment planning. The identification of mandibular flexure as a risk factor emphasises the need for customised prosthetic designs, such as segmented frameworks or those incorporating titanium bases, to mitigate stress concentrations. These insights provide actionable guidance for pre-surgical planning and patient-specific treatment strategies, enhancing long-term outcomes.

Despite its strengths, the study has notable limitations. The retrospective cohort design restricts causal interpretation and depends on existing records, making it vulnerable to selection bias and incomplete data. The single-centre recruitment process and relatively small sample size, limits the generalisability and statistical power of subgroup analyses, particularly for maxillary versus mandibular outcomes. Furthermore, by not accounting for confounding variables such as oral hygiene factors, a well-established risk for peri-implantitis, limits a comprehensive understanding of complication dynamics. Additionally, the study does not explore alternative materials or designs in depth, leaving an opportunity for future comparative studies to examine options like titanium-based or hybrid frameworks.

To conclude, this study contributes valuable long-term data on monolithic zirconia frameworks in IFCDPs. It provides a foundation for innovation in material science and prosthetic design, paving the way for more tailored and durable solutions in implant dentistry.

Related Articles

Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia

X-linked hypophosphataemia (XLH) is a rare metabolic bone disorder caused by pathogenic variants in the PHEX gene, which is predominantly expressed in osteoblasts, osteocytes and odontoblasts. XLH is characterized by increased synthesis of the bone-derived phosphaturic hormone fibroblast growth factor 23 (FGF23), which results in renal phosphate wasting with consecutive hypophosphataemia, rickets, osteomalacia, disproportionate short stature, oral manifestations, pseudofractures, craniosynostosis, enthesopathies and osteoarthritis. Patients with XLH should be provided with multidisciplinary care organized by a metabolic bone expert. Historically, these patients were treated with frequent doses of oral phosphate supplements and active vitamin D, which was of limited efficiency and associated with adverse effects. However, the management of XLH has evolved in the past few years owing to the availability of burosumab, a fully humanized monoclonal antibody that neutralizes circulating FGF23. Here, we provide updated clinical practice recommendations for the diagnosis and management of XLH to improve outcomes and quality of life in these patients.

Influence of supporting teeth quantity of surgical guide on the accuracy of the immediate implant in the maxillary central incisor: an in vitro study

Guided surgery for immediate anterior implants aims to reduce the time required for aesthetic and functional immediate loading. However, the limited surface area of anterior teeth for guide stabilization may affect the accuracy of implant positioning. This in vitro study evaluated the effect of the number of supporting teeth on the accuracy of immediate implants in the maxillary central incisor region.

Efficacy of oral irrigators compared to other interdental aids for managing peri-implant diseases: a systematic review

Peri-implant diseases (peri-implant mucositis and peri-implantitis) are inflammatory conditions that affect the peri-implant tissues and are induced by microbial biofilms (dental plaque) formed around the implant. Removal of biofilm is the fundamental step in managing peri-implant diseases. Interdental cleaning aids such as interdental brush, unitufted brush, or oral irrigation along with regular toothbrushing are recommended for effective plaque control around implants. The present systematic review aims to evaluate the efficacy of home use of oral irrigators compared to other plaque control methods for managing peri-implant diseases.

Evolution of temporomandibular joint reconstruction: from autologous tissue transplantation to alloplastic joint replacement

The reconstruction of the temporomandibular joint presents a multifaceted clinical challenge in the realm of head and neck surgery, underscored by its relatively infrequent occurrence and the lack of comprehensive clinical guidelines. This review aims to elucidate the available approaches for TMJ reconstruction, with a particular emphasis on recent groundbreaking advancements. The current spectrum of TMJ reconstruction integrates diverse surgical techniques, such as costochondral grafting, coronoid process grafting, revascularized fibula transfer, transport distraction osteogenesis, and alloplastic TMJ replacement. Despite the available options, a singular, universally accepted ‘gold standard’ for reconstructive techniques or materials remains elusive in this field. Our review comprehensively summarizes the current available methods of TMJ reconstruction, focusing on both autologous and alloplastic prostheses. It delves into the differences of each surgical technique and outlines the implications of recent technological advances, such as 3D printing, which hold the promise of enhancing surgical precision and patient outcomes. This evolutionary progress aims not only to improve the immediate results of reconstruction but also to ensure the long-term health and functionality of the TMJ, thereby improving the quality of life for patients with end-stage TMJ disorders.

Responses

Your email address will not be published. Required fields are marked *